Procaps Group S.A EBIT

Procaps Group S.A (PROC) currently reports a EBIT of $92M as of September 2023. That compares with $-3.8M in the prior-year period — up 2531.0% year over year. That is below the Healthcare sector average of $22B. Use the charts on this page to explore Procaps Group S.A's EBIT history and peer comparisons.

Procaps Group S.A's EBIT increased from $-3.8M to $92M — a 2531.0% year-over-year increase (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Procaps Group S.A's EBIT of $92M is lower than the Healthcare sector average of $22B. That is roughly 99.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Procaps Group S.A reported $92M in EBIT as of September 2023. That compares with $-3.8M in the prior-year period — up 2531.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $92M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $22B. From there, open related valuation or income-statement pages for Procaps Group S.A, and consider following PROC for alerts when major investors trade the stock.